Research location
Amritsar
Punjab, India
Advertisement
Research activity in Amritsar
Punjab, IndiaCureCurrent currently publishes aggregate city-level research activity for this location: 12 trials and 12 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Amritsar
12 linked trials · page 1 of 1A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or ObesityNCT07861100 · 2026-10-26 · 1 site observation
NOT_YET_RECRUITING
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)NCT05156281 · 2021-12-13 · 1 site observation
ACTIVE_NOT_RECRUITING
An Observational Study to Assess the Prevalence of Heart Failure in Type 2 Diabetes PatientsNCT04072523 · 2019-12-03 · 1 site observation
COMPLETED
Indian Phenotype RegistryNCT03363594 · 2017-12-11 · 1 site observation
COMPLETED
Usage of Dapagliflozin in the Management of Type-2 Diabetes Mellitus: A Real World Evidence Study in Indian PatientsNCT03071016 · 2017-03-04 · 1 site observation
COMPLETED
Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in IndiaNCT02230618 · 2015-11-24 · 1 site observation
COMPLETED
Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus PatientsNCT02588859 · 2015-10-30 · 1 site observation
COMPLETED
Global Non-interventional Heart Failure Disease RegistryNCT02595814 · 2014-07-23 · 1 site observation
TERMINATED
Advance Cardiac Resynchronization Therapy (CRT) RegistryNCT01805154 · 2013-01-01 · 1 site observation
COMPLETED
Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and MetforminNCT01519674 · 2012-06-01 · 1 site observation
COMPLETED
Long-Term Safety and Efficacy Study of Peginterferon Beta-1aNCT01332019 · 2011-04-01 · 1 site observation
COMPLETED
Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple SclerosisNCT00906399 · 2009-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.